Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 939K 863K 804K 1.52M 102M 1.55M 10.36M 4.03M 50.25M 4.03M 3.94M 173M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 723K 664K 619K 1.17M 78.71M 1.19M 7.97M 3.1M 38.69M 3.1M 3.04M 133M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
3 months+40.00%
6 months+133.33%
Current year+133.33%
Current year 0
Extreme 0.0004
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.03
5 years 0
Extreme 0
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 25/06/2019
Director TitleAgeSince
Director/Board Member 64 31/12/2002
Director/Board Member 84 31/12/2004
Director/Board Member - 28/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+600.00%-95.88% 26.37K
+3.75%+10.67%-20.49%+14.67% 2,901B
+0.80%+20.54%-2.13%+743.44% 310B
-1.38%-10.10%+269.83%+972.32% 127B
+0.46%+1.33%+20.00%+59.11% 103B
-0.11%+17.84%+92.84%+164.65% 92.68B
-1.09%-3.93%-16.43%+0.40% 83.71B
-3.80%+16.05%-30.87%+77.98% 63.27B
-2.63%+6.82%+6.46%+73.27% 47.34B
-0.84%+19.44%-45.89%+37.49% 39.67B
Average -0.71%+18.41%+87.33%+204.75% 376.72B
Weighted average by Cap. +1.10%+5.10%-5.31%+113.52%

Financials

2015 2016
Net sales 4.22M 3.69M 3.39M 3.16M 6M 402M 6.09M 40.72M 15.83M 198M 15.85M 15.51M 681M 3.04M 2.66M 2.45M 2.28M 4.32M 290M 4.39M 29.37M 11.42M 143M 11.43M 11.18M 491M
Net income 151K 132K 121K 113K 214K 14.38M 218K 1.46M 566K 7.07M 567K 555K 24.35M -344K -301K -276K -258K -489K -32.75M -496K -3.32M -1.29M -16.1M -1.29M -1.26M -55.48M
Net Debt -340K -297K -273K -255K -483K -32.37M -490K -3.28M -1.27M -15.91M -1.28M -1.25M -54.83M -247K -216K -198K -185K -351K -23.52M -356K -2.38M -926K -11.56M -927K -907K -39.84M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
  1. Stock Market
  2. Stocks
  3. NMXS Stock